NCT06010589View on ClinicalTrials.gov

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 17, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

DWJ1558

DWJ1558

DRUG

DWC202310 and DWC202311

Co-administration of DWC202310 and DWC202311

Trial Locations (1)

Unknown

H Plus YANGJI Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT06010589 - Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter